Deep whole genome sequencing identifies recurrent genomic alterations in commonly used breast cancer cell lines and patient-derived xenograft models.
Niantao DengAndre MinocheKate HarveyMeng LiJuliane WinklerAndrei GogaAlexander SwarbrickPublished in: Breast cancer research : BCR (2022)
Our WGS data provides a comprehensive genome sequencing resource of these models.